You have 9 free searches left this month | for more free features.

spartalizumab

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Oesophageal Adenocarcinoma, Gastric Adenocarcinoma Trial in France (Capmatinib, Spartalizumab)

Not yet recruiting
  • Oesophageal Adenocarcinoma
  • Gastric Adenocarcinoma
  • (no location specified)
Nov 15, 2021

NSCLC Trial in Worldwide (Capmatinib, Spartalizumab, Docetaxel)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Fayetteville, Arkansas
  • +7 more
Jan 21, 2022

Non-small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal SCC Trial in Worldwide (TNO155, Spartalizumab,

Recruiting
  • Non-small Cell Lung Carcinoma
  • +4 more
  • Boston, Massachusetts
  • +8 more
Mar 18, 2022

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Spartalizumab
  • Badalona, Barcelona, Spain
  • +9 more
Aug 13, 2021

Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
Mar 2, 2021

MDS, Leukemia, Myelomonocytic, Chronic Trial (decitabine, Spartalizumab, Sabatolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • (no location specified)
Aug 5, 2022

Nasopharyngeal Carcinoma Trial in Worldwide (Spartalizumab, Investigator choice of chemo)

Completed
  • Nasopharyngeal Carcinoma
  • Spartalizumab
  • Investigator choice of chemotherapy
  • Marietta, Georgia
  • +17 more
Jan 17, 2022